News

Opportunity for Investors of Ready Capital to Lead Lawsuit

Opportunity for Investors of Ready Capital to Lead Lawsuit

Class Action Opportunity for Ready Capital Investors

Investors of Ready Capital Corporation, whose common stock is traded on NYSE under the ticker RC, may have a chance to take action following substantial financial losses. Those who acquired shares between specific dates may be eligible to lead a class action lawsuit stemming from alleged violations in securities regulation.

Understanding the Class Action Lawsuit

The class action lawsuit against Ready Capital is significant due to the claims it makes regarding the company's financial practices. Investors who bought shares during the class period from one date to another may seek to take the lead in the legal proceedings, acting on behalf of others affected. This presents a rare opportunity for affected investors to not only reclaim losses but also potentially hold the company accountable.

Allegations in the Lawsuit

Central to this lawsuit are allegations suggesting that Ready Capital's management misrepresented the financial health of the company. Reports indicate that during the specified period, executives allegedly failed to disclose significant issues regarding non-performing loans within their commercial real estate portfolio. As a result, the financial situation faced by Ready Capital was far worse than the public was led to believe, leading to the lawsuit.

Financial Impact on Investors

In a troubling turn of events, Ready Capital disclosed substantial financial losses, highlighting a $1.80 net loss per share in one quarterly report and a $2.52 loss per share for the entire year. Such drastic losses can understandably affect the trust of investors, which is why legal actions are being taken. Following this disclosure, the stock price fell sharply, directly impacting those who invested within the lawsuit's class period.

The Process to Become Lead Plaintiff

For those interested in taking part in the lawsuit, understanding the lead plaintiff process is critical. Investors can step forward if they believe they have the most at stake and can adequately represent the interests of the class. The Private Securities Litigation Reform Act of 1995 facilitates this process, emphasizing that anyone who held shares during the defined periods may qualify. This democratic process allows for a concerned investor to voice the grievances of many.

Role of the Lead Plaintiff

The appointed lead plaintiff will play a pivotal role throughout the legal proceedings, directing the lawsuit and selecting legal counsel to guide the suit further. It's important to note that financial recovery is accessible to all class members, regardless of whether they serve as lead plaintiff. Hence, active participation in the process is encouraged, as it potentially leads to accountability and restitution for all impacted shareholders.

About Robbins Geller Rudman & Dowd LLP

Robbins Geller Rudman & Dowd LLP serves as one of the leading law firms guiding investors in such class action lawsuits. The firm has established a reputation for achieving impressive financial recoveries for its clients over the years. With over 200 dedicated attorneys and a vast array of successful case outcomes in securities law, they represent the interests of investors with skill and determination. Their past results provide a strong reassurance for current investors contemplating participation in this ongoing lawsuit.

Frequently Asked Questions

What is the class action lawsuit about?

The lawsuit revolves around claims that Ready Capital Corporation misrepresented their financial health and failed to disclose issues with non-performing loans.

Who can become the lead plaintiff in the class action?

Any investor who purchased shares during the class period can seek to become the lead plaintiff, with preference generally given to those with the greatest financial interest.

What are the financial implications for affected investors?

Those affected can potentially reclaim losses through the lawsuit and hold the company accountable for its actions that led to financial damages.

What role does the law firm play in the lawsuit?

The law firm, specifically Robbins Geller, will provide legal representation and guide the lead plaintiff throughout the litigation process.

Can other investors still benefit from the lawsuit?

Yes, all investors part of the class can benefit from any recoveries, not just the lead plaintiff.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Intestinal Worms: New Science and Old Challenges

Updated Category News Views 48

Intestinal Worms: A Modern Twist on an Old Tale Just when you thought you'd heard it all, here comes the notion that intestinal worms might actually be good for us. The stuff of cringe-worthy junior high biology classes is now strutting its stuff in F1000Research. Sounds odd? Maybe, but there's a half-century of science behind it. Old Foes with New Friends These...

Continue Reading
PG&E Breaks Ground with Global Emergency Accreditation

Updated Category News Views 24

Pioneering Emergency Management Standards The landscape of emergency management just got a shakeup, folks. PG&E, an energy utility giant that powers the lives of over 16 million Californians, bagged a distinction that doesn’t roll around every day—indeed, the first of its caliber in the utility sector. Earning accreditation from the big dogs at the Emergency...

Continue Reading
Transforming Healthcare Leadership Through Systemic Change

Updated Category News Views 22

Reframing Physician Leadership for Systemic Transformation Here we go, diving into some serious change-making in the healthcare sphere. If you've ever wandered through a hospital corridor, you've likely felt the tension between docs and the suits. The American Association for Physician Leadership (AAPL) is stirring the pot with a fresh book that might just be the catalyst...

Continue Reading
Blue Moon Metals Scraps Major Acquisition Plan

Updated Category News Views 87

Blue Moon Metals' Acquisition Detour Blue Moon Metals Inc. (NASDAQ: BMM), a name that's been stirring up chatter for its ambitious mining ventures, has waved goodbye to its planned acquisition of 33 U.S.-based tungsten and antimony projects. This move, announced on October 30, 2026, may have caught some investors off guard. The acquisition sounded like a good fit: a...

Continue Reading
Mondel?z Bites into Undercover: Snack Market Impact

Updated Category News Views 46

Snack World Shake-Up: Mondel?z Steps In Ever find yourself browsing the snack aisle, wondering how many brands are duking it out for shelf space? Well, brace yourself, because Mondel?z International — the big cheese in the global snack game — is grabbing a sizeable bite of Undercover Snacks. This is no small news in the land of chocolate-covered and frosted quinoa...

Continue Reading
Endava's Securities Class Action Heats Up Wall Street

Updated Category News Views 13

A Head-Spinning Fall for Endava Endava's recent tumble on the NYSE has investors rubbing their eyes in disbelief. A jaw-dropping 25% slide in share value on September 22, 2026, has everyone scrambling for answers. Looks like some serious skeletons were hiding deep in Endava's closets—management snafus and fuzzy accounting being at the forefront. This debacle has peeled...

Continue Reading
Z Squared Eyes 150 MW Expansion at Arkansas Site

Updated Category News Views 48

Turning Power into Potential at Union County Next stop, Union County, Arkansas. Z Squared Inc. (Nasdaq: ZSQR) isn't just talking shop; they're getting down to work. With a freshly acquired site through Paradox Data, LLC, Z Squared's planning to turn vision into reality. The site's already armed with 8 MW of juice, all ready to roll, but their ambitions shoot up to 150 MW...

Continue Reading
Midterms and Retirement: Evaluate Precious Metals

Updated Category News Views 134

Understanding the Financial Climate Amid Midterms Here we go, folks—the red, white, and blue circus we know as the midterms is back in town. And while politicians do their song and dance, you gotta ask yourself if your investments are strong enough to weather any storm those election winds might blow your way. American Independence Gold is waving the flag, telling folks...

Continue Reading
Navigating Holiday Eating with GLP-1 Support

Updated Category News Views 49

GLP-1 Programs: A New Holiday Challenge As if the holidays weren't already a puzzle with family dinners and over-the-top office parties, folks on a GLP-1 program have another set of questions, like navigating a buffet without guilt. Ain’t no sugarcoating it—December throws every routine straight out the window. It's not just about what pie to eat, but how to keep your...

Continue Reading
Viatris Bids for Pacira: Strategic Healthcare Move

Updated Category News Views 51

Viatris Takes Strategic Step With Pacira Acquisition You ever notice how in the pharmaceutical games, it's not always the pills but the strategic moves that make the money? Viatris Inc., the global healthcare heavyweight, has just rolled the dice. They've initiated a tender offer to acquire Pacira BioSciences, a player in the non-opioid pain management market. Here's the...

Continue Reading

Top 5 Most Recently Viewed Articles

Matthews International Prepares for Q2 Fiscal 2025 Earnings Call

Updated Category News Views 340

Matthews International's Upcoming Earnings Release PITTSBURGH — Matthews International Corporation (Nasdaq: MATW) has exciting plans to unveil its financial results for the second quarter of fiscal year 2025. The earnings announcement is scheduled for Wednesday after the market closes. This is an important time for investors, as it provides insights into the company's...

Continue Reading
Investigation Launched for Proficient Auto Logistics, Inc.

Updated Category News Views 291

Overview of Proficient Auto Logistics, Inc. Proficient Auto Logistics, Inc. (NASDAQ: PAL) has come under scrutiny as Pomerantz LLP initiates an investigation into the company's financial practices. The firm is exploring whether Proficient Auto and its leadership have engaged in securities fraud or any unethical business methods. Details of the Investigation The ongoing...

Continue Reading
Abacus Global Management Sees Revenue Surge with $44.1M Q1

Updated Category News Views 124

Abacus Global Management Reports Exceptional Q1 Performance Abacus Global Management, Inc. (NASDAQ: ABL), a prominent player in the alternative asset management sector, has shared impressive financial results for the first quarter of 2025. The company's total revenue exceeded expectations as it reached $44.1 million, effectively doubling from the same quarter of the...

Continue Reading
Korro Bio's Upcoming Conferences: Innovations in RNA Editing

Updated Category News Views 242

Korro Bio's Upcoming Conferences Korro Bio, Inc. (NASDAQ: KRRO) is set to engage with investors and the wider scientific community during several upcoming conferences this September. These engagements are pivotal for displaying its advancements in RNA editing technology, a focus of the company. Citi's Biopharma Conference Dr. Ram Aiyar, the Chief Executive Officer of...

Continue Reading
Qualcomm’s Impressive Q3 Financial Results Reveal Growth

Updated Category News Views 111

Qualcomm's Strong Q3 Performance Qualcomm Inc (NASDAQ: QCOM) has showcased outstanding financial results for the third quarter, demonstrating resilience and growth in a competitive market. The company reported a revenue of $10.365 billion, reflecting a 10% increase compared to the previous year and exceeding analysts' estimates of $10.333 billion. Key Financial Highlights...

Continue Reading